CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-05 | Opaleye Management Inc. 10% owner | Sale | −5,500 | $5.85 | $32K | 132,100 |
| 2021-08-04 | Opaleye Management Inc. 10% owner | Sale | −100,000 | $5.75 | $575K | 3,451,100 |
| 2021-08-04 | Opaleye Management Inc. 10% owner | Sale | −4,000 | $5.75 | $23K | 137,600 |
| 2021-06-15 | Opaleye Management Inc. 10% owner | Sale | −101,000 | $8.07 | $815K | 3,551,100 |
| 2021-06-15 | Opaleye Management Inc. 10% owner | Sale | −4,000 | $8.07 | $32K | 141,600 |
| 2021-06-15 | Opaleye Management Inc. 10% owner | Sale | −101,000 | $8.07 | $815K | 3,551,100 |
| 2021-06-15 | Opaleye Management Inc. 10% owner | Sale | −4,000 | $8.07 | $32K | 141,600 |
| 2021-06-03 | BRYNJELSEN SEAN President & CEO | Purchase | +5,000 | $5.96 | $30K | 1,030,000 |
| 2021-05-27 | Opaleye Management Inc. 10% owner | Sale | −121,400 | $8.49 | $1.0M | 3,652,100 |
| 2021-05-27 | Opaleye Management Inc. 10% owner | Sale | −4,600 | $8.49 | $39K | 145,600 |
| 2021-05-26 | Opaleye Management Inc. 10% owner | Sale | −65,500 | $8.57 | $561K | 3,773,500 |
| 2021-05-26 | Opaleye Management Inc. 10% owner | Sale | −2,800 | $8.57 | $24K | 150,200 |
| 2021-05-25 | Opaleye Management Inc. 10% owner | Sale | −46,000 | $8.53 | $392K | 3,839,000 |
| 2021-05-25 | Opaleye Management Inc. 10% owner | Sale | −2,000 | $8.53 | $17K | 153,000 |
| 2021-05-03 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (Right to buy) | +19,655 | 59,555 | ||
| 2021-05-03 | RIEDEL NORBERT G Director | Grant or award · Stock Option (Right to buy) | +19,655 | 59,555 | ||
| 2021-05-03 | BRYNJELSEN SEAN President & CEO | Grant or award · Stock Option(Right to buy) | +245,000 | 1,185,000 | ||
| 2021-05-03 | MAIER PAUL V Director | Grant or award · Stock Option(Right to buy) | +19,655 | 59,555 | ||
| 2021-05-03 | Troutman William Wilson CFO and Secretary | Grant or award · Stock Option(Right to buy) | +125,000 | 656,200 | ||
| 2021-05-03 | Adams Jennifer McKie Director | Grant or award · Stock Option (Right to buy) | +28,133 | 28,133 |
Page 11 of 13 · 249 trades